PRODUCTION OF VIBRIO-CHOLERAE GHOSTS (VCG) BY EXPRESSION OF A CLONED PHAGE LYSIS GENE - POTENTIAL FOR VACCINE DEVELOPMENT

被引:38
作者
EKO, FO [1 ]
SZOSTAK, MP [1 ]
WANNER, G [1 ]
LUBITZ, W [1 ]
机构
[1] UNIV MUNICH,INST BOT,D-80638 MUNICH,GERMANY
关键词
VIBRIO CHOLERAE; GENE E EXPRESSION; HIV-1 REVERSE TRANSCRIPTASE; VACCINE DEVELOPMENT;
D O I
10.1016/0264-410X(94)90249-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The protein E-specific lysis mechanism of the Escherichia coli-specific bacteriophage PhiX174 was employed to produce Vibrio cholerae ghosts (VCG). VCG consist of both rounded and collapsed cells that have lost their cytoplasmic contents through an E-specific hole in the cell envelope. These ghosts are proposed as non-living material for immunization against cholera. A specific membrane anchor sequence was used to insert the human immunodeficiency virus type 1 (HIV-1) reverse transcripase (RT) fusion protein into the cell envelope of v. cholerae. The identity of the expression products was confirmed by Western blot analysis employing an RT-specific monoclonal antibody. HIV-1 RT was chosen as a model for the purpose of evaluating heterologous gene expression in V. cholerae and the carrier potential of VCG. Intraperitoneal immunization of mice was used to evaluate the immunogenic potential of VCG. Preliminary results showed significant seroconversions to intact whole-cell vibrio antigens in mice immunized with VCG or a heat-killed whole-cell vibrio preparation.
引用
收藏
页码:1231 / 1237
页数:7
相关论文
共 28 条
[1]  
BAUDRY B, 1991, 27TH P JOINT C CHOL, P46
[2]  
BLASI U, 1985, J GEN MICROBIOL, V131, P1107
[3]  
CARDENAS L, 1992, CLIN MICROBIOL REV, V5, P328
[4]   FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - RESULTS FROM 3-YEAR FOLLOW-UP [J].
CLEMENS, JD ;
SACK, DA ;
HARRIS, JR ;
VANLOON, F ;
CHAKRABORTY, J ;
AHMED, F ;
RAO, MR ;
KHAN, MR ;
YUNUS, M ;
HUDA, N ;
STANTON, BF ;
KAY, BA ;
WALTER, S ;
EECKELS, R ;
SVENNERHOLM, AM ;
HOLMGREN, J .
LANCET, 1990, 335 (8684) :270-273
[5]  
EVANS D G, 1988, FEMS (Federation of European Microbiological Societies) Microbiology Immunology, V47, P117, DOI 10.1111/j.1574-6968.1988.tb02363.x
[6]  
EVANS D J JR, 1988, FEMS (Federation of European Microbiological Societies) Microbiology Immunology, V47, P9, DOI 10.1016/0378-1097(88)90164-4
[7]  
FORCARETA T, 1991, MOL MICROBIOL, V5, P2547
[8]  
Harlow E., 1988, ANTIBODIES LAB MANNU, P471
[9]   AN ORAL-B SUBUNIT - WHOLE CELL VACCINE AGAINST CHOLERA [J].
HOLMGREN, J ;
SVENNERHOLM, AM ;
JERTBORN, M ;
CLEMENS, J ;
SACK, DA ;
SALENSTEDT, R ;
WIGZELL, H .
VACCINE, 1992, 10 (13) :911-914
[10]   RECOMBINANT ATTENUATED VIBRIO-CHOLERAE STRAINS USED AS LIVE ORAL VACCINES [J].
KAPER, JB ;
LEVINE, MM .
RESEARCH IN MICROBIOLOGY, 1990, 141 (7-8) :901-906